Annefleur M. Koopen

1.2k total citations
9 papers, 128 citations indexed

About

Annefleur M. Koopen is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Annefleur M. Koopen has authored 9 papers receiving a total of 128 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Annefleur M. Koopen's work include Gut microbiota and health (6 papers), Diet and metabolism studies (5 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Annefleur M. Koopen is often cited by papers focused on Gut microbiota and health (6 papers), Diet and metabolism studies (5 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Annefleur M. Koopen collaborates with scholars based in Netherlands, Sweden and Denmark. Annefleur M. Koopen's co-authors include Max Nieuwdorp, Albert K. Groen, Hilde Herrema, Koen Wortelboer, Willem M. de Vos, Julia J. Witjes, Jens J. Holst, Torsten P. M. Scheithauer, Ilias Attaye and Eduardo L. Almeida and has published in prestigious journals such as Frontiers in Microbiology, Nutrients and Diabetes Obesity and Metabolism.

In The Last Decade

Annefleur M. Koopen

9 papers receiving 126 citations

Peers

Countries citing papers authored by Annefleur M. Koopen

Since Specialization

Citations

This map shows the geographic impact of Annefleur M. Koopen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annefleur M. Koopen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annefleur M. Koopen more than expected).

Fields of papers citing papers by Annefleur M. Koopen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annefleur M. Koopen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annefleur M. Koopen. The network helps show where Annefleur M. Koopen may publish in the future.

Co-authorship network of co-authors of Annefleur M. Koopen

This figure shows the co-authorship network connecting the top 25 collaborators of Annefleur M. Koopen. A scholar is included among the top collaborators of Annefleur M. Koopen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annefleur M. Koopen. Annefleur M. Koopen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Oral Anaerobutyricum soehngenii augments glycemic control in type 2 diabetes 2024 ·iScience ·Ilias Attaye, Julia J. Witjes, Annefleur M. Koopen, (unknown), (unknown), Koen Wortelboer, Didier Collard, E. Marleen Kemper, Maaike Winkelmeijer, Jens J. Holst, Stanley L. Hazen, Folkert Kuipers, Erik S.G. Stroes, Albert K. Groen, Willem M. de Vos, Max Nieuwdorp, Hilde Herrema	6
2	Disentangle beneficial effects of strain engraftment after fecal microbiota transplantation in subjects with MetSyn 2024 ·Gut Microbes ·(unknown), Mark Davids, (unknown), Koen Wortelboer, Annick V. Hartstra, Annefleur M. Koopen, Pieter F. de Groot, Evgeni Levin, Max Nieuwdorp	1
3	From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii 2022 ·Frontiers in Medicine ·Koen Wortelboer, Annefleur M. Koopen, Hilde Herrema, Willem M. de Vos, Max Nieuwdorp, (unknown)	21
4	Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome 2021 ·Frontiers in Microbiology ·Annefleur M. Koopen, Eduardo L. Almeida, Ilias Attaye, Julia J. Witjes, Elena Rampanelli, (unknown), Marleen Kemper, Johannes H.M. Levels, Alinda W.M. Schimmel, Hilde Herrema, Torsten P. M. Scheithauer, (unknown), Lars Ove Dragsted, Bolette Hartmann, Jens J. Holst, Paul W. O’Toole, Albert K. Groen, Max Nieuwdorp	40
5	Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk 2021 ·Metabolites ·Moritz V. Warmbrunn, Annefleur M. Koopen, Nicolien C. de Clercq, Pieter F. de Groot, Ruud S. Kootte, Kristien E. Bouter, Kasper W. ter Horst, Annick V. Hartstra, Mireille J. Serlie, Mariëtte T. Ackermans, Maarten R. Soeters, Daniël H. van Raalte, Mark Davids, Max Nieuwdorp, Albert K. Groen	4
6	Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition 2020 ·Nutrients ·Annefleur M. Koopen, Nicolien C. de Clercq, Moritz V. Warmbrunn, Hilde Herrema, Mark Davids, Pieter F. de Groot, Ruud S. Kootte, Kristien E. Bouter, Max Nieuwdorp, Albert K. Groen, Andrei Prodan	9
7	Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects 2019 ·Physiological Reports ·Guido J. Bakker, Johan G. Schnitzler, Siroon Bekkering, Nicolien C. de Clercq, Annefleur M. Koopen, Annick V. Hartstra, (unknown), Torsten P. M. Scheithauer, Maaike Winkelmeijer, Geesje M. Dallinga‐Thie, Patrice D. Cani, E. Marleen Kemper, Maarten R. Soeters, Jeffrey Kroon, Albert K. Groen, Daniël H. van Raalte, Hilde Herrema, Max Nieuwdorp	12
8	Iloprost infusion prevents the insulin‐induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patients 2018 ·Diabetes Obesity and Metabolism ·Anna L. Emanuel, Nicolien C. de Clercq, Annefleur M. Koopen, (unknown), Mireille J. Serlie, Daniël H. van Raalte, Mark H.H. Kramer, Max Nieuwdorp, Etto C. Eringa, Erik H. Serné	7
9	Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk 2016 ·Current Opinion in Lipidology ·Annefleur M. Koopen, Albert K. Groen, Max Nieuwdorp	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact